Limbic selected for FDA pilot to test voice AI therapy with Medicare enrollees
Limbic has been selected for an FDA pilot in which it will test voice AI therapy with Medicare enrollees (26 August 2026).
Who is affected and how
- doctor
- Mental health AI tools are entering an authorised pilot with measurable outcomes.
- medtech company
- The FDA pilot shows the regulatory path for mental health AI products.
- health policy
- Medicare's scope also brings the question of how AI therapy is funded to the fore.
Sources
- Limbic selected to FDA pilot, will test voice AI therapy with Medicare enrolleesfierce healthcare · Aug 26, 2026
- Limbic selected to FDA pilot, will test voice AI therapy with Medicare enrollees - Fierce Healthcarefiercehealthcare.com · Aug 26, 2026
- FDA selects Limbic for TEMPO pilot to test voice AI therapy on... | Pivot Newspivotnews.ai · Aug 27, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.